← Back to Screener
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)
Price$6.58
Favorite Metrics
Price vs S&P 500 (26W)-24.74%
Price vs S&P 500 (4W)-23.04%
Market Capitalization$9.44M
All Metrics
Book Value / Share (Quarterly)$0.12
P/TBV (Annual)0.61x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.52
Price vs S&P 500 (YTD)-57.67%
EPS (TTM)$-19.85
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-19.85
EPS (Annual)$-1.91
ROI (Annual)-73.89%
Cash / Share (Quarterly)$0.26
ROA (Last FY)-57.05%
EBITD / Share (TTM)$-6.83
ROE (5Y Avg)-751.37%
Cash Flow / Share (Annual)$-30.69
P/B Ratio3.70x
P/B Ratio (Quarterly)2.13x
Net Income / Employee (Annual)$-3
Net Interest Coverage (TTM)-14.21x
ROA (TTM)-125.16%
EPS Incl Extra (Annual)$-1.91
Current Ratio (Annual)3.57x
Quick Ratio (Quarterly)0.94x
3-Month Avg Trading Volume0.09M
52-Week Price Return20.86%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.10
52-Week High$41.80
EPS Excl Extra (Annual)$-1.91
26-Week Price Return-20.76%
Quick Ratio (Annual)3.36x
13-Week Price Return-44.62%
Total Debt / Equity (Annual)0.32x
Current Ratio (Quarterly)1.04x
Enterprise Value$10.082
Revenue / Employee (Annual)$0
Cash / Share (Annual)$54.91
3-Month Return Std Dev97.82%
Net Income / Employee (TTM)$-5
ROE (Last FY)-97.37%
Net Interest Coverage (Annual)-10.63x
EPS Basic Excl Extra (Annual)$-1.91
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)1.03x
EPS Incl Extra (TTM)$-19.85
ROI (TTM)-141.01%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$34.07
Price vs S&P 500 (52W)-8.97%
Year-to-Date Return-55.02%
5-Day Price Return13.07%
EPS Normalized (Annual)$-1.91
ROA (5Y Avg)-101.78%
Month-to-Date Return-1.67%
Cash Flow / Share (TTM)$-0.00
EBITD / Share (Annual)$-2.03
LT Debt / Equity (Annual)0.25x
ROI (5Y Avg)-151.18%
LT Debt / Equity (Quarterly)0.79x
EPS Basic Excl Extra (TTM)$-19.85
P/TBV (Quarterly)2.56x
P/B Ratio (Annual)0.58x
Book Value / Share (Annual)$35.95
Price vs S&P 500 (13W)-45.30%
Beta1.70x
Revenue / Share (TTM)$0.00
ROE (TTM)-210.50%
52-Week Low$5.01
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares | — | — | — | — | $6.58 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. The company's pipeline of three products targets multiple indications including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, and Epidermolysis Bullosa.